Task: Answer the multiple-choice question.
Question: Which drug exhibits a -3.842% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1c([N+](=O)[O-])c(C(=O)N2CCCC2)nn1C
b Cc1cc(C)nc(N2CCCC(C(=O)NCCc3cccc(F)c3)C2)n1
Answer: b. Cc1cc(C)nc(N2CCCC(C(=O)NCCc3cccc(F)c3)C2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(N2CCCC(C(=O)NCCc3cccc(F)c3)C2)n1
Cc1cc(C)nc(N2CCCC(C(=O)NCCc3cccc(F)c3)C2)n1
1-(4,6-dimethylpyrimidin-2-yl)-N-[2-(3-fluorophenyl)ethyl]piperidine-3-carboxamide